Sanofi (EPA:SAN)
France · Delayed Price · Currency is EUR 76.23
-0.25 (-0.33%)
Jul 10, 2026, 5:39 PM CET
Sanofi Employees
Sanofi had 74,846 employees as of December 31, 2025. The number of employees decreased by 8,032 or -9.69% compared to the previous year.
Employees
74,846
Change (1Y)
-8,032
Growth (1Y)
-9.69%
Revenue / Employee
€632,686
Profits / Employee
€100,941
Market Cap
91.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 74,846 | -8,032 | -9.69% |
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 155,975 |
| emeis Société anonyme | 84,586 |
| Clariane SE | 70,685 |
| Eurofins Scientific SE | 65,694 |
| Ramsay Générale de Santé | 40,000 |
| bioMérieux | 15,226 |
| Sartorius Stedim Biotech | 10,456 |
| Virbac | 6,442 |
Sanofi News
- 11 hours ago - Sanofi (SNY) Secures FDA Approval for Subcutaneous Sarclisa Escena in Multiple Myeloma - GuruFocus
- 11 hours ago - Sanofi (SNY) Receives FDA Approval for Subcutaneous Sarclisa Escena - GuruFocus
- 12 hours ago - Sanofi Says FDA Approves Sarclisa Escena SC As First Anticancer Treatment Via On-body Injector - Nasdaq
- 13 hours ago - Sanofi announces subcutaneous Sarclisa Escena approved in U.S. - TheFly
- 13 hours ago - Press Release: Sanofi's subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector - GlobeNewsWire
- 13 hours ago - US FDA approves Sanofi's wearable injector form of blood cancer drug - Reuters
- 2 days ago - Sanofi price target lowered to $49 from $52 at Morgan Stanley - TheFly
- 2 days ago - EU seeks feedback on Sanofi's commitments addressing suspected anti-competitive behaviour - Reuters